NASDAQ:SWAV
Delisted

Shockwave Medical Stock News

etoro logo Buy SWAV
*Your capital is at risk
$334.75
+0 (+0%)
At Close: Aug 29, 2024
Shockwave Medical (SWAV) has added ~12% in the post-market Thursday after the company reported better-than-expected financials for Q4 2021 and set its 2022 revenue guidance ahead of…
ShockWave Medical press release (SWAV): Q4 GAAP EPS of $0.34 beats by $0.25.Revenue of $84.18M (+270.8% Y/Y) beats by $8.75M.Shockwave Medical projects revenue for the FY2022 to…
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2021.
It was a tough day on Wall Street overall.
ShockWave Medical's (SWAV) CEO Doug Godshall on Q4 2021 Results - Earnings Call Transcript
Shockwave Medical (SWAV) delivered earnings and revenue surprises of 385.71% and 11.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ShockWave Medical Q4 2021 Earnings Preview

10:35pm, Wednesday, 16'th Feb 2022 Seeking Alpha

Shockwave Medical (SWAV) Reports Next Week: Wall Street Expects Earnings Growth

08:01pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SANTA CLARA, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascul

Should Investors Sell the Rumor With ShockWave Medical?

12:03pm, Friday, 04'th Feb 2022 The Motley Fool
The opposite of the old adage to "buy the rumor, sell the news" doesn't apply to ShockWave.

Should Investors Sell the Rumor With ShockWave Medical?

12:03pm, Friday, 04'th Feb 2022 The Motley Fool
The opposite of the old adage to "buy the rumor, sell the news" doesn''t apply to ShockWave.
SANTA CLARA, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular
The opposite of the old adage to "buy the rumor, sell the news" doesn't apply to ShockWave.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE